The Bioinformatics CRO Revenue and Competitors

Niceville, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • The Bioinformatics CRO's estimated annual revenue is currently $4M per year.(i)
  • The Bioinformatics CRO's estimated revenue per employee is $155,000

Employee Data

  • The Bioinformatics CRO has 26 Employees.(i)
  • The Bioinformatics CRO grew their employee count by 0% last year.

The Bioinformatics CRO's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director OperationsReveal Email/Phone
3
Operations ManagerReveal Email/Phone
4
Marketing ManagerReveal Email/Phone
5
Bioinformatics ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is The Bioinformatics CRO?

The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Bioinformatics CRO News

2022-04-17 - A Guide to Decentralized Biotech | Future

This CRO directory outlines the full range of possible services. Sponsored research agreements (SRAs), in which biotech companies pay academic...

2022-04-17 - Biodegradable gel boosts immune system's attack on several ...

... academic institute or contact research organisation (CRO) and want to hear about all of the latest innovation in vaccine development,...

2022-03-30 - Selvita sums up 2021 and announces Development Strategy ...

The bioinformatics segment (Ardigen, a subsidiary company) closed 2021 ... will allow Selvita to become the leading global preclinical CRO.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.9M403%N/A
#2
$7.5M4111%N/A
#3
$8.5M435%N/A
#4
$1.7M5315%N/A
#5
$7.2M530%N/A